Acthar Gel (repository corticotropin injection) treats African Americans with sarcoidosis as effectively as it does patients of other races, a study suggests. The study, “Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physician Assessment of Patient Medical Records,” was published in Therapeutics…
News
Nearly a quarter of sarcoidosis patients were found to have clinically silent cardiac involvement, in which standard heart symptoms are not observed, recent research indicated. Readily available cardiac screening tools, when used in combination, may help to rule out the presence of this hidden disease manifestation and avoid…
To help boost awareness of sarcoidosis and support those affected by the complex and often misunderstood disorder, the Foundation for Sarcoidosis Research (FSR) is hosting its first in-person training of its Global Sarcoidosis Clinic Alliance (FSR-GSCA) volunteer patient leaders at the Cleveland Clinic. The training takes place…
Scientists at the University of Colorado are planning a study to better classify sarcoidosis as it affects the eyes, called ocular sarcoidosis. Having a grasp on the specific biological mechanisms that drive sarcoidosis in different patients could lead to more targeted treatments, researchers say. “Improving our ability to define…
People with sarcoidosis are significantly more likely to develop venous thromboembolism (VTE), which occurs when a blood clot forms in a vein, over 10 years than the general population, a nationwide study in Denmark suggests. And while there are substantial differences in clinical characteristics between those who develop VTE…
The percentage of natural killer (NK) immune cells in the airways were predictive of a more advanced stage of lung damage and multi-organ involvement in people with pulmonary sarcoidosis, according to a recent report. Altogether, the scientists believe these cells could be “a good prognostic marker” of a more…
Elevated blood levels of total blood cholesterol and low levels of high density lipoprotein cholesterol (HDL) — commonly called the “good” cholesterol — showed a significant correlation with sarcoidosis, according to a retrospective study conducted in China. These findings suggest HDL and total blood cholesterol “could be regarded as…
An immunosuppressive medication that’s used to prevent organ rejection after transplantation successfully treated cutaneous sarcoidosis, a type of sarcoidosis of the skin, in most patients in a small clinical trial. Sirolimus, which suppresses a signaling pathway called mTOR, reduced or eliminated skin granulomas and its benefits persisted for…
Menopausal hormone therapy (MHT) is linked to a 25% higher risk of developing sarcoidosis, according to a recent study in Sweden. The therapy consists of administering sex hormones, either estrogen alone or an estrogen and progesterone combination, to treat common menopausal symptoms such as “hot flashes.” The highest risk…
Bone fractures, particularly those of the spine, are a common complication among people with sarcoidosis, according to a study that assessed nearly 400 patients. Data showed that sarcoidosis-related lung involvement and reduced lung function were risk factors for major bone fractures. Chest X-rays examining lung involvement, as well as…
Recent Posts
- Simple blood test may predict cardiac sarcoidosis outcomes
- To scoot or not to scoot: Using a mobility aid with a dynamic disability
- Mobile app for breathing meditation may reduce sarcoidosis fatigue
- New report highlights unmet needs and treatment burdens in sarcoidosis
- Cardiac sarcoidosis symptoms at diagnosis help predict long-term risk
- Methotrexate is safer second-line sarcoidosis treatment than MMF
- A holiday gift guide for your loved one with sarcoidosis
- FSR gathers global leaders to drive progress in sarcoidosis research
- New genetic clues connect sarcoidosis with lung cancer risk
- When patients and caregivers swap roles, empathy usually follows